H L Allen|L L Iversen - JoVE Visualize

Showing results (101-110 of 114) with videos related to

Pageof 12

Sort By:

European Journal of Pharmacology|April 29, 1992

L-687,306: a functionally selective and potent muscarinic M1 receptor agonistS B Freedman, S Patel, E A Harley, et al.

Differentiation; Research in Biological Diversity|January 1, 1985

Effect of tamoxifen on H-Y antigen expression and gonadal development in chicken embryosG C Koo, H L Allen, R A Long, et al.

British Journal of Pharmacology|October 1, 1991

Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptorsA T McKnight, J J Maguire, N J Elliott, et al.

Neuroscience Letters|August 19, 1983

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's typeL L Iversen, M N Rossor, G P Reynolds, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994

Mechanism of inositol monophosphatase, the putative target of lithium therapyS J Pollack, J R Atack, M R Knowles, et al.

Teratology|June 1, 1995

Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in ratsS G Spence, H L Allen, M A Cukierski, et al.

Journal of Medicinal Chemistry|April 1, 1990

Novel quinuclidine-based ligands for the muscarinic cholinergic receptorJ Saunders, M Cassidy, S B Freedman, et al.

Cancer Research|March 1, 1986

Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogeneR D Storer, R B Stein, J F Sina, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1991

The toxicity of a fluorinated-biphenyl HMG-CoA reductase inhibitor in beagle dogsR J Gerson, H L Allen, G R Lankas, et al.

Molecular Pharmacology|November 1, 1994

Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.

Pageof 12

Showing results (101-110 of 114) with videos related to

Sort By:

Pageof 12

European Journal of Pharmacology|April 29, 1992

L-687,306: a functionally selective and potent muscarinic M1 receptor agonistS B Freedman, S Patel, E A Harley, et al.

Differentiation; Research in Biological Diversity|January 1, 1985

Effect of tamoxifen on H-Y antigen expression and gonadal development in chicken embryosG C Koo, H L Allen, R A Long, et al.

British Journal of Pharmacology|October 1, 1991

Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptorsA T McKnight, J J Maguire, N J Elliott, et al.

Neuroscience Letters|August 19, 1983

Loss of pigmented dopamine-beta-hydroxylase positive cells from locus coeruleus in senile dementia of Alzheimer's typeL L Iversen, M N Rossor, G P Reynolds, et al.

Proceedings of the National Academy of Sciences of the United States of America|June 21, 1994

Mechanism of inositol monophosphatase, the putative target of lithium therapyS J Pollack, J R Atack, M R Knowles, et al.

Teratology|June 1, 1995

Defining the susceptible period of developmental toxicity for the AT1-selective angiotensin II receptor antagonist losartan in ratsS G Spence, H L Allen, M A Cukierski, et al.

Journal of Medicinal Chemistry|April 1, 1990

Novel quinuclidine-based ligands for the muscarinic cholinergic receptorJ Saunders, M Cassidy, S B Freedman, et al.

Cancer Research|March 1, 1986

Malignant transformation of a preneoplastic hamster epidermal cell line by the EJ c-Ha-ras-oncogeneR D Storer, R B Stein, J F Sina, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|February 1, 1991

The toxicity of a fluorinated-biphenyl HMG-CoA reductase inhibitor in beagle dogsR J Gerson, H L Allen, G R Lankas, et al.

Molecular Pharmacology|November 1, 1994

Biological properties of the benzodiazepine amidine derivative L-740,093, a cholecystokinin-B/gastrin receptor antagonist with high affinity in vitro and high potency in vivoS Patel, A J Smith, K L Chapman, et al.

Pageof 12